Factors predicting efficacy of oxaliplatin in combination with 5-fluorouracil (5-FU) ± folinic acid in a compassionate-use cohort of 481 5-FU-resistant advanced colorectal cancer patients

A statistical analysis was performed on the patient data collected from two compassionate-use programmes using oxaliplatin (Eloxatin®) + 5-fluorouracil (5-FU) ± folinic acid (FA), to identify predictive factors for oxaliplatin-based salvage treatment in patients with 5-FU-resistant advanced colorect...

Descripción completa

Detalles Bibliográficos
Autores principales: Bensmaïne, M A, Marty, M, Gramont, A de, Brienza, S, Lévi, F, Ducreux, M, François, E, Gamelin, E, Bleiberg, H, Cvitkovic, E
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2001
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364084/
https://www.ncbi.nlm.nih.gov/pubmed/11506488
http://dx.doi.org/10.1054/bjoc.2001.1953

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364084/
https://www.ncbi.nlm.nih.gov/pubmed/11506488
http://dx.doi.org/10.1054/bjoc.2001.1953

Ejemplares similares